Viking's weight loss pill program has a couple of issues, including the fierce competitors who have

The latest trading day saw Viking Therapeutics, Inc. (VKTX) settling at $28.53, representing a +2.88

In the closing of the recent trading day, Viking Therapeutics, Inc. (VKTX) stood at $27.73, denoting

VK2735's oral maintenance study could expand Viking Therapeutics' obesity strategy by helping sustai

Truist Securities analyst Joon Lee maintains Viking Therapeutics (NASDAQ:VKTX) with a Buy and low

Viking Therapeutics faces dilution and rising obesity competition, but VK2735's pipeline progress co

VK2375 is being developed in both oral and subcutaneous formulations for the potential treatment of

Study to Explore Oral Maintenance Dosing Regimens Following Initial Weight Loss with Subcutaneous VK

Get 'em while they're still on sale. Catalysts are on the horizon.

Eli Lilly's new data show Foundayo's cardiovascular safety and metabolic benefits, while EloraTZP de

Viking Therapeutics raised $575 million in a supplementary public offering after positive trial resu

Viking Therapeutics, Inc. (VKTX) closed the most recent trading day at $30.51, moving 6.41% from the

Could this be what Novo needs to turn things around?

Viking Therapeutics, Inc. (VKTX) concluded the recent trading session at $32.74, signifying a +2.92%

Viking Therapeutics' leading candidate recently performed well in a maintenance clinical trial. The

Viking Therapeutics' recent clinical trial results for its leading weight loss candidate were excell

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

Investors looking for some compelling growth opportunities outside of tech may want to consider thes

Gross Proceeds to Viking Approximately $575 Million SAN DIEGO, Sept. 28, 2026 /PRNewswire/ -- Viking

Kuehn Law Encourages Investors of Viking Therapeutics, Inc. to Contact Law FirmPR NewswireNEW YORK,

Viking Therapeutics delivered strong VK2735 maintenance trial results in obesity, showing robust ind

NEW YORK, Sept. 28, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is inve

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or H

Benzinga examined the prospects for many investors’ favorite stocks over the last week — here’s a lo

Stocks pared a sharp morning selloff after sources said US and Iranian negotiators are discussing a

U.S. stocks fell Thursday: Dow -0.7%, S&P 500 -0.46%, Nasdaq -0.7%. Oil jumped 4.4%; Darden miss

A Viking Therapeutics announcement about an equity and debt offering fuels a reaction in the market.

Gainers Profusa (NASDAQ:PFSA) stock increased by 112.5% to $4.36 during Thursday's pre-market s

U.S. futures fell as Stitch Fix plunged 18% on weak FY27 guidance; MGM, Viking Therapeutics and othe

Viking Therapeutics, Inc. (NASDAQ:VKTX), a clinical-stage biopharmaceutical company focused on the d

GlucoTrack surged 117.7% premarket after Lokahi Therapeutics signed its first external partnership;

Viking Therapeutics shares are moving lower in extended trading Wednesday after the company announce

Gainers GlucoTrack (NASDAQ:GCTK) stock moved upwards by 90.6% to $3.87 during Wednesday's after

Viking Therapeutics stock jumps 40% after VK2735 shows sustained weight loss with less frequent dosi

Viking Therapeutics, Inc. (NASDAQ:VKTX), a clinical-stage biopharmaceutical company focused on the d

Truist Securities analyst Joon Lee maintains Viking Therapeutics (NASDAQ:VKTX) with a Buy and rai

JAGX, IONQ, VKTX, XNDU, GRAB were among the stocks seen trending on Tuesday, Sept. 22, 2026.

U.S. stocks were mixed: Nasdaq and S&P 500 rose while the Dow fell; communication services gaine

Nasdaq 100 printed an intraday record on AI enthusiasm while financials slid nearly 2% and crude fel

Gainers Jaguar Health (NASDAQ:JAGX) stock increased by 304.5% to $10.8 during Tuesday's regular

U.S. stocks rose, led by On Holding's 13% surge after strong guidance and a $1B buyback; Viking

Viking Therapeutics reports positive VK2735 study results showing effective weight maintenance with

Gainers Decoy Therapeutics (NASDAQ:DCOY) shares rose 84.0% to $4.71 during Tuesday's pre-market

VICR: 13% | Vicor shares are trading higher after the company raised its Q3 revenue guidance. VKTX:

Results Demonstrate Viability of Monthly and Every Other Week Dosing Regimens for Maintaining Weight

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

Viking Therapeutics shares are dropping Tuesday amid a risk-off trade, though its longer-term uptren

US stock futures lower, MongoDB shares down 13.4% in pre-market trading after earnings beat estimate

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

JP Morgan analyst Hardik Parikh maintains Viking Therapeutics (NASDAQ:VKTX) with a Overweight and